Hundreds of potential investors will be meeting in Amsterdam next month for the Cannabis Capital Convention. This is the first cannabis conference for investors and entrepreneurs in the Netherlands.
The Cannabis Capital Convention, which is initiated and organized by publicist and professional investor Michael Kraland, will be held on September 26, 2018, at the Eye Filmmuseum Amsterdam, right at the center of the capital city.
This event aims to inform investors about the investing opportunities that the cannabis industry presents. It will feature speakers ranging from product specialists, cannabis production companies, and analysts from leading investment banks.
Participants will not only learn from discussions and gain insights into cannabis investment opportunities, but they will get the chance to network with investors and influencers in the industry during lunch and drinks.
More specifically, the roster of speakers will include:
- Robert Cheney, CEO of C21 Investments Inc. Cheney, an investor and entrepreneur with a strong background in film, media, internet technology, and telecommunications, is focused on building exceptional management teams and on investment opportunities with strong growth potential.
- Randy Torcom, VP-Marketing at C21 Investments Inc. Torcom is responsible for C21 products and oversees the company’s international brand strategy.
- Javier Gonzalez Lastra and Matt Reid, Analysts at Berenberg Bank. Based in Hamburg, Germany, Berenberg Bank is one of the leading privately owned banks in Europe, focusing on Investment Banking, Wealth and Asset Management, and Corporate Banking. Javier and Reid will talk about the investment universe and its impact on beverages.
- Tjalling Erkelens, Founder & CEO of Bedrocan. Bedrocan is a medical cannabis producer. Since 2003, Bedrocan has been providing standardized pharmaceutical-quality cannabis to the Dutch government. It is the world’s oldest legal company providing several chemically different medical cannabis varieties for patients and as raw material for the pharmaceutical industry.
- Mauricio Agudelo, CFO at Bedrocan International. Prior to joining Bedrocan International, Agudelo was one of the founding members and the managing director of a Luxembourg-based private equity fund investing in global cannabis-related enterprises.
- Sky Pinnick, CEO of Phantom Farms. Phantom Farms is one of the largest marijuana brands in Oregon, USA.
- Stephen Murphy, Managing Director at Prohibition Partners. Prohibition Partners is a source of intelligence and insights into Europe’s cannabis industry. Murphy is also co-founder of the Cannabis Europa and European Cannabis Holdings.
- Eric R. Shoemaker, President of Swell Companies Ltd. Swell Companies is a cannabis processing company based in Portland, Oregon.
- Michael J. Thale, Director for Brand Marketing at Swell Companies Ltd. Thale leads the development of innovative and new extract-based consumer goods that identify with cannabis consumers.
- Juriën Koster, Founder & CEO of Cannabis Industry Europe. CIE provides insights on the EU market and serves as intermediate for different players in the cannabis industry.
- Danny Brody, Vice President of Investor Relations at The Green Organic Dutchman Holdings Ltd. Brody specializes in finance and cannabis and has presented at various conferences around the world.
- Christine Smith, CEO of Grön Chocolate and GrönCBD. Grön Chocolate and GrönCBD, is one of Oregon’s largest licensed edible processors and the first licensed CBD cafe and tasting room in North America.
How will investments apply to Europe’s cannabis industry?
The Cannabis Capital Convention recognizes The Cannabis Industry 2017 Annual Report’s projection that medical and recreational cannabis sales will take off in 2018 with a reach of $4.75 billion. According to report, the forecast for 2025 is for cannabis sales to hit $25 billion. This is a result of recreational cannabis legalization in Canada and in several states in the U.S. It is also expected that legalization will extend to other U.S. states after the elections this November. And as more countries and more states in the U.S. legalize the use and production of cannabis products, more new businesses will begin to exist.
In North America alone, the emerging cannabis industry has been acknowledged as a profitable market, and this has led to multiple companies and funds investing in it.
The cannabis market in Europe is also emerging. In the last six months, Europe’s cannabis industry has grown more than it has in the last five years. Many European countries have already made progress in terms of legalization, and Europe’s cannabis industry has already received its share of investments.
There is no question that Europe has also benefited from global cannabis-related developments, especially those that pertain to North America. European governments are now more capable of understanding the benefits that cannabis legislation brings, especially financially and socially.